ONTOLOGY REPORT - ANNOTATIONS
| Term: | Digestive System Diseases |
|
| Accession: | RDO:0003763
|
browse the term
|
| Definition: | Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS). |
| Synonyms: | exact_synonym: | Digestive System Disease |
| | primary_id: | MESH:D004066 |
|
|
Adenoma, Islet Cell
|
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
|
IEP |
2 |
1,923,309 |
1,970,238 |
RGD:2308920 |
RGD |
Adenoma, Liver Cell
|
| G |
A2m |
alpha-2-macroglobulin |
|
|
IED |
4 |
158,103,711 |
158,153,423 |
RGD:1358261 |
RGD |
| G |
Hp |
haptoglobin |
|
|
IEP |
19 |
39,443,016 |
39,447,566 |
RGD:1626391 |
RGD |
Aganglionosis, total intestinal
|
| Q |
Gdil1 |
Gastrointestinal dilation QTL 1 |
|
|
IAGP |
2 |
57,161,998 |
75,806,439 |
RGD:6480217 |
RGD |
| S |
AR-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480217 |
RGD |
| S |
F344-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480215 |
RGD |
| S |
LE-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480215 |
RGD |
Alagille Syndrome
|
| G |
Jag1 |
jagged 1 |
|
|
ISS |
3 |
125,181,063 |
125,216,481 |
RGD:6482232 |
RGD |
| G |
Jag1 |
jagged 1 |
|
|
ISS |
3 |
125,181,063 |
125,216,481 |
RGD:1580651 |
RGD |
| G |
Jag1 |
jagged 1 |
|
|
ISS |
3 |
125,181,063 |
125,216,481 |
RGD:6482237 |
RGD |
| G |
Jag1 |
jagged 1 |
|
|
ISS |
3 |
125,181,063 |
125,216,481 |
RGD:7240710 |
OMIM |
| G |
Notch2 |
notch 2 |
|
|
ISS |
2 |
192,839,350 |
192,986,589 |
RGD:1580762 |
RGD |
| G |
Notch2 |
notch 2 |
|
|
ISS |
2 |
192,839,350 |
192,986,589 |
RGD:7240710 |
OMIM |
alpha 1-Antitrypsin Deficiency
|
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:7240710 |
OMIM |
Anus, Imperforate
|
| G |
Pqbp1 |
polyglutamine binding protein 1 |
|
|
ISS |
X |
26,638,460 |
26,642,640 |
RGD:7240710 |
OMIM |
Barrett Esophagus
|
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
Severity |
ISS |
1 |
195,310,027 |
195,336,224 |
RGD:6483521 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
IAGP |
8 |
4,333,773 |
4,354,284 |
RGD:7207058 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:7207058 |
RGD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
|
ISS |
8 |
4,249,938 |
4,259,675 |
RGD:7207058 |
RGD |
| G |
Ptges |
prostaglandin E synthase |
|
|
IEP |
3 |
9,946,194 |
9,957,538 |
RGD:2300107 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:1642603 |
RGD |
Bile acid synthesis defect, congenital, 4
|
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
|
ISS |
2 |
60,332,292 |
60,344,326 |
RGD:7240710 |
OMIM |
Biliary Atresia
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686894 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
Disease_progression |
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:7184431 |
RGD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
|
ISS |
6 |
134,022,016 |
134,043,058 |
RGD:1625622 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581370 |
RGD |
Carcinoma, Hepatocellular
|
| G |
A2m |
alpha-2-macroglobulin |
|
|
IED |
4 |
158,103,711 |
158,153,423 |
RGD:1358261 |
RGD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
|
IEP |
5 |
70,493,357 |
70,583,729 |
RGD:1598532 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
IEP |
1 |
82,686,233 |
82,726,544 |
RGD:2313299 |
RGD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
|
IEP |
10 |
64,308,826 |
64,312,415 |
RGD:2301136 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:7240710 |
OMIM |
| G |
Apoe |
apolipoprotein E |
|
|
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:6903288 |
RGD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
|
IEP |
19 |
52,854,657 |
52,856,625 |
RGD:5135035 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
ISS |
1 |
20,998,894 |
21,011,275 |
RGD:4140476 |
RGD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
|
IEP |
4 |
32,758,866 |
32,776,220 |
RGD:2316006 |
RGD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
|
ISS |
3 |
10,578,717 |
10,622,332 |
RGD:4140479 |
RGD |
| G |
Axin1 |
axin 1 |
|
|
ISS |
10 |
15,409,373 |
15,462,726 |
RGD:1300371 |
RGD |
| G |
Axin1 |
axin 1 |
|
|
ISS |
10 |
15,409,373 |
15,462,726 |
RGD:7240710 |
OMIM |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
|
IEP |
6 |
25,272,416 |
25,296,266 |
RGD:2303530 |
RGD |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
|
IAGP |
6 |
25,272,416 |
25,296,266 |
RGD:5132587 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
IEP |
8 |
50,765,645 |
51,108,962 |
RGD:2289095 |
RGD |
| G |
Capn3 |
calpain 3 |
|
|
IEP |
3 |
106,946,878 |
106,998,274 |
RGD:1600777 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:7240710 |
OMIM |
| G |
Ccne1 |
cyclin E1 |
|
|
IEP |
1 |
90,568,189 |
90,577,426 |
RGD:2289277 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:2313413 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
IED |
19 |
36,442,693 |
36,512,091 |
RGD:2289638 |
RGD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
|
IEP |
20 |
20,018,044 |
20,044,030 |
RGD:2316317 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
IAGP |
5 |
108,908,749 |
108,916,380 |
RGD:1600822 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
IEP |
5 |
108,908,749 |
108,916,380 |
RGD:1600816 |
RGD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
Severity |
IED |
20 |
11,920,816 |
11,982,468 |
RGD:1600906 |
RGD |
| G |
Csk |
c-src tyrosine kinase |
|
|
IEP |
8 |
61,381,336 |
61,386,013 |
RGD:5134372 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
8 |
125,978,161 |
125,987,670 |
RGD:734850 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
8 |
125,978,161 |
125,987,670 |
RGD:7240710 |
OMIM |
| G |
Ctsb |
cathepsin B |
|
|
IED |
15 |
42,402,829 |
42,423,701 |
RGD:2315605 |
RGD |
| G |
Ctsl1 |
cathepsin L1 |
|
|
IED |
17 |
6,288,013 |
6,294,174 |
RGD:2315605 |
RGD |
| G |
Ep300 |
E1A binding protein p300 |
|
|
IEP |
7 |
119,938,507 |
120,008,886 |
RGD:2312274 |
RGD |
| G |
Fhit |
fragile histidine triad |
|
|
IED |
15 |
15,823,461 |
17,329,184 |
RGD:632723 |
RGD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
|
IEP |
1 |
212,430,453 |
212,432,741 |
RGD:632698 |
RGD |
| G |
Gc |
group specific component |
|
|
IEP |
14 |
20,166,243 |
20,197,060 |
RGD:5509919 |
RGD |
| G |
Gmps |
guanine monphosphate synthetase |
|
|
IEP |
2 |
153,804,512 |
153,840,009 |
RGD:5135537 |
RGD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
|
IEP |
1 |
202,822,925 |
202,825,601 |
RGD:2306187 |
RGD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
|
IEP |
X |
139,929,647 |
139,961,616 |
RGD:5135035 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEP |
1 |
202,906,624 |
202,915,231 |
RGD:2311523 |
RGD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
|
ISS |
1 |
42,253,273 |
42,341,646 |
RGD:1624323 |
RGD |
| G |
Il6st |
interleukin 6 signal transducer |
|
|
IEP |
2 |
43,806,301 |
43,842,365 |
RGD:1626706 |
RGD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
|
IED |
5 |
76,449,470 |
76,571,458 |
RGD:2317680 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Susceptibility |
ISS |
7 |
56,996,694 |
57,020,926 |
RGD:2317357 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
IEP |
4 |
43,134,183 |
43,211,355 |
RGD:2317495 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317575 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:1600123 |
RGD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
|
IAGP |
MT |
5,323 |
6,867 |
RGD:2302301 |
RGD |
| G |
Mt-nd5 |
mitochondrially encoded NADH dehydrogenase 5 |
|
|
IEP |
MT |
11,736 |
13,565 |
RGD:2302316 |
RGD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
|
IEP |
4 |
117,517,611 |
117,529,128 |
RGD:2302305 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
IEP |
7 |
98,953,142 |
98,958,060 |
RGD:7240695 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
7 |
98,953,142 |
98,958,060 |
RGD:6903288 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Severity |
ISS |
7 |
98,953,142 |
98,958,060 |
RGD:7241004 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Treatment |
IED |
7 |
98,953,142 |
98,958,060 |
RGD:7240567 |
RGD |
| G |
Pdgfrl |
platelet-derived growth factor receptor-like |
|
|
ISS |
16 |
54,664,213 |
54,742,494 |
RGD:7240710 |
OMIM |
| G |
Pfas |
phosphoribosylformylglycinamidine synthase |
|
|
IEP |
10 |
55,745,617 |
55,761,944 |
RGD:5135276 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:2290476 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:7240710 |
OMIM |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
|
IEP |
14 |
33,509,364 |
33,543,743 |
RGD:5135035 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IEP |
13 |
64,427,288 |
64,432,978 |
RGD:2300283 |
RGD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
|
IPM |
7 |
110,933,298 |
111,084,554 |
RGD:2292584 |
RGD |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
Disease_progression |
ISS |
4 |
179,927,255 |
179,951,742 |
RGD:2317370 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IEP |
2 |
181,616,581 |
181,628,144 |
RGD:1643188 |
RGD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
|
IEP |
2 |
58,769,164 |
58,797,229 |
RGD:2315050 |
RGD |
| G |
Soat2 |
sterol O-acyltransferase 2 |
|
|
ISS |
7 |
140,890,902 |
140,903,999 |
RGD:1581190 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:1581242 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581375 |
RGD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
|
IED |
9 |
9,788,378 |
9,797,639 |
RGD:1581428 |
RGD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
|
IEP |
5 |
115,047,195 |
115,196,172 |
RGD:1601490 |
RGD |
| G |
Tfrc |
transferrin receptor |
|
|
IEP |
11 |
69,976,258 |
69,998,098 |
RGD:2292036 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
IEP |
4 |
120,355,649 |
120,437,772 |
RGD:2317471 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
IEP |
8 |
120,593,595 |
120,680,453 |
RGD:1601598 |
RGD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
|
ISS |
|
|
|
RGD:2317348 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISS |
10 |
56,399,721 |
56,411,150 |
RGD:1302543 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISS |
10 |
56,399,721 |
56,411,150 |
RGD:7240710 |
OMIM |
| G |
Tspy1 |
testis specific protein, Y-linked 1 |
|
|
ISS |
|
|
|
RGD:2315447 |
RGD |
| G |
Vav1 |
vav 1 guanine nucleotide exchange factor |
|
|
IEP |
|
|
|
RGD:2306008 |
RGD |
| G |
Xdh |
xanthine dehydrogenase |
|
|
IEP |
6 |
21,417,685 |
21,590,015 |
RGD:5135059 |
RGD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
|
IEA |
1 |
79,834,167 |
79,860,300 |
RGD:1331525 |
RGD |
| Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
|
IED |
8 |
43,313,902 |
87,122,960 |
RGD:629566 |
RGD |
| Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
|
IED |
6 |
41,300,997 |
115,238,799 |
RGD:629566 |
RGD |
| Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
|
IED |
3 |
25,775,548 |
118,863,223 |
RGD:629566 |
RGD |
| Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
|
IED |
4 |
1 |
29,414,068 |
RGD:737884 |
RGD |
| Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
|
IED |
18 |
53,847,682 |
86,863,412 |
RGD:737884 |
RGD |
| Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
|
IED |
1 |
198,396,580 |
220,639,653 |
RGD:619609 |
RGD |
| Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
|
IED |
1 |
220,639,539 |
232,579,992 |
RGD:619609 |
RGD |
| Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
|
IED |
1 |
224,822,211 |
267,910,886 |
RGD:619609 |
RGD |
| Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
|
IED |
4 |
58,550,170 |
93,498,821 |
RGD:619609 |
RGD |
| Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
|
IED |
|
|
|
RGD:619609 |
RGD |
| Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
|
IED |
4 |
106,554,769 |
171,204,531 |
RGD:629566 |
RGD |
| Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
|
IED |
1 |
146,971,846 |
228,781,113 |
RGD:629566 |
RGD |
| Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
|
IED |
16 |
4,304,396 |
50,266,190 |
RGD:629566 |
RGD |
| Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
|
IED |
1 |
180,678,929 |
265,343,617 |
RGD:737884 |
RGD |
| Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
|
IED |
14 |
41,608,939 |
89,192,873 |
RGD:737884 |
RGD |
| Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
|
IED |
15 |
2,306,220 |
43,057,384 |
RGD:737884 |
RGD |
| S |
ACI/N |
A X C 9935, Irish |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BUF/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
F344.BN-(D16Mit5-D16Rat75) |
|
|
|
IED |
16 |
24,131,965 |
24,132,402 |
RGD:1599590 |
RGD |
| S |
F344/NRrrc |
|
|
|
TAS |
|
|
|
RGD:619598 |
RGD |
Carcinoma, Islet Cell
|
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317661 |
RGD |
Carcinoma, Pancreatic Ductal
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:2325211 |
RGD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
|
ISS |
X |
51,051,758 |
51,096,036 |
RGD:2325210 |
RGD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
Disease_progression |
ISS |
1 |
199,780,772 |
199,791,855 |
RGD:2325243 |
RGD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
Disease_progression |
ISS |
16 |
71,446,498 |
71,526,108 |
RGD:2325249 |
RGD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
|
ISS |
6 |
54,695,633 |
54,716,858 |
RGD:2325659 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
14 |
19,126,935 |
19,142,214 |
RGD:2325677 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
|
ISS |
8 |
73,897,618 |
73,934,041 |
RGD:2325731 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
Disease_progression |
ISS |
8 |
73,897,618 |
73,934,041 |
RGD:2317307 |
RGD |
| G |
Anxa5 |
annexin A5 |
|
|
ISS |
2 |
122,949,210 |
122,979,757 |
RGD:2317538 |
RGD |
| G |
Anxa8 |
annexin A8 |
|
|
ISS |
16 |
9,715,644 |
9,730,584 |
RGD:2325735 |
RGD |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISS |
1 |
78,996,677 |
78,999,960 |
RGD:2325793 |
RGD |
| G |
Calr |
calreticulin |
|
|
ISS |
19 |
24,964,775 |
24,969,670 |
RGD:2326165 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
14 |
62,052,510 |
62,057,201 |
RGD:4110816 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
14 |
62,052,510 |
62,057,201 |
RGD:4110818 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
ISS |
1 |
163,156,914 |
163,166,969 |
RGD:4110816 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5490301 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5490524 |
RGD |
| G |
Cldn4 |
claudin 4 |
|
|
ISS |
12 |
22,816,134 |
22,817,932 |
RGD:2317592 |
RGD |
| G |
Egf |
epidermal growth factor |
|
Disease_progression |
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:2317644 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317747 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317741 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
Disease_progression |
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317758 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317756 |
RGD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
Disease_progression |
ISS |
|
|
|
RGD:2317790 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317809 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317811 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Resistance |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317806 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2317639 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317649 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317652 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:2317264 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:2317264 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317248 |
RGD |
| G |
Krt7 |
keratin 7 |
|
Disease_progression |
ISS |
7 |
140,160,829 |
140,226,474 |
RGD:2317307 |
RGD |
| G |
L1cam |
L1 cell adhesion molecule |
|
Severity |
ISS |
X |
159,784,792 |
159,801,553 |
RGD:6483447 |
RGD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
|
ISS |
12 |
17,607,250 |
17,614,508 |
RGD:2317697 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Severity |
ISS |
7 |
56,996,694 |
57,020,926 |
RGD:2317416 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Onset |
ISS |
7 |
56,996,694 |
57,020,926 |
RGD:2317414 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317294 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317530 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
Susceptibility |
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317648 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317664 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Severity |
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:2325746 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325844 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325830 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326065 |
RGD |
| G |
Msln |
mesothelin |
|
Disease_progression |
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326055 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2317983 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Disease_progression |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324633 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Disease_progression |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324616 |
RGD |
| G |
Muc3a |
mucin 3A, cell surface associated |
|
Disease_progression |
ISS |
|
|
|
RGD:2324946 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324946 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
Disease_progression |
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324942 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
|
ISS |
|
|
|
RGD:2324986 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
Disease_progression |
ISS |
|
|
|
RGD:2324907 |
RGD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
|
ISS |
1 |
201,962,340 |
201,997,147 |
RGD:2324986 |
RGD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
|
ISS |
10 |
82,591,705 |
82,601,075 |
RGD:5132867 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2325254 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
ISS |
3 |
4,631,797 |
4,677,640 |
RGD:2325323 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
ISS |
3 |
4,631,797 |
4,677,640 |
RGD:2325324 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
Disease_progression |
ISS |
1 |
133,925,530 |
134,302,139 |
RGD:2325660 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
ISS |
1 |
133,925,530 |
134,302,139 |
RGD:2325663 |
RGD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
|
ISS |
16 |
31,144,028 |
31,144,544 |
RGD:2325781 |
RGD |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
|
ISS |
9 |
45,203,344 |
45,292,624 |
RGD:2324870 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
Disease_progression |
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2317461 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:2317185 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
Severity |
ISS |
3 |
6,605,782 |
6,689,224 |
RGD:2317461 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:2317811 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324975 |
RGD |
| G |
Smo |
smoothened, frizzled family receptor |
|
|
ISS |
4 |
56,623,494 |
56,645,571 |
RGD:2324981 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2325019 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
Disease_progression |
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317500 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317498 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
Disease_progression |
ISS |
|
|
|
RGD:2325025 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
|
|
|
RGD:2325022 |
RGD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
|
ISS |
20 |
9,545,077 |
9,564,261 |
RGD:2325152 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
Disease_progression |
ISS |
7 |
127,666,518 |
127,671,624 |
RGD:2325155 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
|
ISS |
4 |
149,529,396 |
149,536,289 |
RGD:2325022 |
RGD |
Caroli Disease
|
| G |
Angpt2 |
angiopoietin 2 |
|
|
IEP |
16 |
75,891,757 |
75,942,255 |
RGD:2314213 |
RGD |
Cartilage-hair hypoplasia
|
| G |
Rmrp |
RNA component of mitochondrial RNA processing endoribonuclease |
|
|
ISS |
15 |
26,789,869 |
26,790,125 |
RGD:7240710 |
OMIM |
Cholestasis, benign recurrent intrahepatic 1
|
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
|
ISS |
18 |
60,748,738 |
60,829,650 |
RGD:7240710 |
OMIM |
Cholestasis, benign recurrent intrahepatic 2
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Cholestasis, Intrahepatic
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
Susceptibility |
ISS |
|
|
|
RGD:1598583 |
RGD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
Susceptibility |
ISS |
4 |
21,946,274 |
22,004,328 |
RGD:1300324 |
RGD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
|
ISS |
4 |
21,946,274 |
22,004,328 |
RGD:1300325 |
RGD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
|
ISS |
4 |
21,946,274 |
22,004,328 |
RGD:1300324 |
RGD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
Susceptibility |
ISS |
18 |
60,748,738 |
60,829,650 |
RGD:1599397 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5135233 |
RGD |
| G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
|
ISS |
1 |
187,085,808 |
187,089,078 |
RGD:1599971 |
RGD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
|
IEP |
5 |
151,524,685 |
151,528,000 |
RGD:2311605 |
RGD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
IED |
7 |
26,189,759 |
26,307,061 |
RGD:1625202 |
RGD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
ISS |
7 |
26,189,759 |
26,307,061 |
RGD:1580984 |
RGD |
Cholestasis, intrahepatic of pregnancy
|
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
|
ISS |
4 |
21,946,274 |
22,004,328 |
RGD:7240710 |
OMIM |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
|
ISS |
18 |
60,748,738 |
60,829,650 |
RGD:7240710 |
OMIM |
Cholestasis, progressive familial intrahepatic 1
|
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
|
ISS |
18 |
60,748,738 |
60,829,650 |
RGD:7240710 |
OMIM |
Cholestasis, progressive familial intrahepatic 2
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
|
ISS |
|
|
|
RGD:7240710 |
OMIM |
Cholestasis, progressive familial intrahepatic 3
|
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
|
ISS |
4 |
21,946,274 |
22,004,328 |
RGD:7240710 |
OMIM |
Cystic Fibrosis
|
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
ISS |
1 |
263,025,655 |
263,027,055 |
RGD:5129107 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:5129107 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:4145099 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:5129107 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:6767553 |
RGD |
| G |
C5 |
complement component 5 |
|
Severity |
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130162 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
ISS |
10 |
70,279,161 |
70,283,762 |
RGD:4145455 |
RGD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
|
ISS |
19 |
10,641,376 |
10,642,827 |
RGD:4145491 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4143275 |
RGD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:5130907 |
RGD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:5130902 |
RGD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
|
ISS |
8 |
128,759,943 |
128,769,341 |
RGD:4145632 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
Susceptibility |
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144796 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144794 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140440 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140481 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:734772 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140442 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140464 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140401 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140439 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140435 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140465 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140428 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140429 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140394 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140436 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140422 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140450 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4139910 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140438 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Disease_progression |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140392 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
No_Association |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140393 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:7240710 |
OMIM |
| G |
Clca1 |
chloride channel accessory 1 |
|
|
ISS |
2 |
243,057,135 |
243,084,146 |
RGD:4145657 |
RGD |
| G |
Clcn2 |
chloride channel, voltage-sensitive 2 |
|
|
IED |
11 |
82,427,792 |
82,441,293 |
RGD:704390 |
RGD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
|
ISS |
5 |
145,374,596 |
145,394,045 |
RGD:5133738 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135456 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135034 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135034 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135034 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135034 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135456 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
ISS |
9 |
73,470,943 |
73,477,315 |
RGD:5135034 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:4145632 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
Severity |
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:4889126 |
RGD |
| G |
Defb4 |
defensin beta 4 |
|
|
ISS |
16 |
75,442,005 |
75,445,196 |
RGD:4892267 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:4145062 |
RGD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
|
ISS |
8 |
82,724,429 |
82,762,848 |
RGD:5134682 |
RGD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
|
ISS |
2 |
203,532,363 |
203,537,135 |
RGD:5135040 |
RGD |
| G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
|
ISS |
10 |
31,585,703 |
31,610,825 |
RGD:5135530 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145410 |
RGD |
| G |
Hspa1a |
heat shock protein 1A |
|
|
ISS |
20 |
3,945,716 |
3,959,552 |
RGD:6767553 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4312589 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4889105 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4889130 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889551 |
RGD |
| G |
Il18bp |
interleukin 18 binding protein |
|
|
ISS |
1 |
159,471,809 |
159,473,288 |
RGD:4889551 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
Severity |
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142849 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Severity |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142844 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143181 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143181 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143175 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143275 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:5128672 |
RGD |
| G |
Il9 |
interleukin 9 |
|
|
ISS |
17 |
14,068,757 |
14,071,880 |
RGD:5128699 |
RGD |
| G |
Il9r |
interleukin 9 receptor |
|
|
ISS |
10 |
15,678,793 |
15,690,250 |
RGD:5128699 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:5128720 |
RGD |
| G |
Lep |
leptin |
|
Severity |
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128819 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
|
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:6767553 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
Severity |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889443 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
Severity |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889447 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
Severity |
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891053 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129526 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130723 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
|
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:5130986 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
severity |
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:5130968 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
IEP |
2 |
181,399,482 |
181,403,640 |
RGD:5131272 |
RGD |
| G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
|
IEP |
|
|
|
RGD:5131426 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
|
ISS |
|
|
|
RGD:5131191 |
RGD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
|
ISS |
1 |
201,962,340 |
201,997,147 |
RGD:5131194 |
RGD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
|
ISS |
1 |
201,962,340 |
201,997,147 |
RGD:5131191 |
RGD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
|
ISS |
9 |
61,798,141 |
61,831,964 |
RGD:6484688 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
Disease_progression |
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132627 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132865 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132868 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891958 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892049 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
ISS |
7 |
123,729,774 |
123,807,090 |
RGD:5683626 |
RGD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
|
IEP |
4 |
69,185,877 |
69,189,080 |
RGD:1599967 |
RGD |
| G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
|
ISS |
1 |
213,437,202 |
213,438,498 |
RGD:5135022 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135298 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135523 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISS |
20 |
1,412,553 |
1,416,692 |
RGD:5144066 |
RGD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
Severity |
ISS |
6 |
128,461,775 |
128,469,309 |
RGD:5147439 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143403 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143381 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143403 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143502 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145125 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:7240710 |
OMIM |
| G |
Tlr4 |
toll-like receptor 4 |
|
Severity |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144179 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144105 |
RGD |
| G |
Tlr5 |
toll-like receptor 5 |
|
Resistance |
ISS |
13 |
99,025,501 |
99,029,755 |
RGD:5129499 |
RGD |
| G |
Tlr5 |
toll-like receptor 5 |
|
|
ISS |
13 |
99,025,501 |
99,029,755 |
RGD:5129506 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130208 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142846 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
TAS |
|
|
|
RGD:628479 |
RGD |
Exocrine Pancreatic Insufficiency
|
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140401 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Onset |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140448 |
RGD |
| G |
Sbds |
Shwachman-Bodian-Diamond syndrome |
|
|
ISS |
12 |
27,457,313 |
27,466,472 |
RGD:1599541 |
RGD |
Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis
|
| G |
Cox4i2 |
cytochrome c oxidase subunit IV isoform 2 (lung) |
|
|
ISS |
3 |
143,103,348 |
143,114,236 |
RGD:7240710 |
OMIM |
Fatty Liver
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
|
IEP |
5 |
70,493,357 |
70,583,729 |
RGD:1598534 |
RGD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
|
IEP |
|
|
|
RGD:1598602 |
RGD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
|
IEP |
10 |
82,986,552 |
83,030,799 |
RGD:2301064 |
RGD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
|
IED |
10 |
72,483,772 |
72,677,134 |
RGD:1625727 |
RGD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
|
IED |
12 |
43,388,679 |
43,492,993 |
RGD:1625727 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
IEP |
11 |
79,908,291 |
79,911,065 |
RGD:1599139 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686883 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686674 |
RGD |
| G |
Adk |
adenosine kinase |
|
|
ISS |
15 |
3,071,412 |
3,458,891 |
RGD:1300259 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:1559320 |
RGD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
|
ISS |
5 |
156,501,739 |
156,558,727 |
RGD:1601177 |
RGD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
|
ISS |
7 |
16,261,623 |
16,267,852 |
RGD:1625354 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
IEP |
6 |
31,508,060 |
31,548,083 |
RGD:2325770 |
RGD |
| G |
Cat |
catalase |
|
|
IEP |
3 |
88,654,077 |
88,686,212 |
RGD:5130871 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:6893500 |
RGD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
IEP |
9 |
65,907,211 |
66,017,942 |
RGD:4144089 |
RGD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
|
ISS |
9 |
63,170,785 |
63,234,727 |
RGD:734818 |
RGD |
| G |
Ctsb |
cathepsin B |
|
|
IEP |
15 |
42,402,829 |
42,423,701 |
RGD:2315513 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:1626302 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
IEP |
1 |
200,918,521 |
200,928,919 |
RGD:4892244 |
RGD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
Induced |
ISS |
4 |
104,412,200 |
104,415,981 |
RGD:1626440 |
RGD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
|
ISS |
6 |
26,173,798 |
26,191,433 |
RGD:1599882 |
RGD |
| G |
Hfe |
hemochromatosis |
|
No_Association |
ISS |
17 |
48,469,927 |
48,478,502 |
RGD:1601460 |
RGD |
| G |
Hfe |
hemochromatosis |
|
|
ISS |
17 |
48,469,927 |
48,478,502 |
RGD:1601452 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
IEP |
13 |
43,953,900 |
43,957,766 |
RGD:2308948 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145478 |
RGD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
|
IPM |
X |
30,505,850 |
30,533,002 |
RGD:4145478 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
IED |
8 |
53,936,584 |
53,943,228 |
RGD:4889416 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:1626661 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307258 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IAGP |
4 |
456,799 |
461,376 |
RGD:2307264 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2311137 |
RGD |
| G |
Insig1 |
insulin induced gene 1 |
|
Severity |
ISS |
4 |
2,577,468 |
2,585,682 |
RGD:2308857 |
RGD |
| G |
Insig1 |
insulin induced gene 1 |
|
|
IEP |
4 |
2,577,468 |
2,585,682 |
RGD:2308857 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
Severity |
ISS |
13 |
33,331,951 |
33,345,132 |
RGD:2308857 |
RGD |
| G |
Jak2 |
Janus kinase 2 |
|
|
ISS |
1 |
232,915,995 |
232,974,763 |
RGD:6483019 |
RGD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
|
ISS |
8 |
20,259,178 |
20,266,351 |
RGD:6893372 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:2311137 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
|
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:1580580 |
RGD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
|
ISS |
2 |
235,613,710 |
235,654,848 |
RGD:1625483 |
RGD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
|
ISS |
3 |
58,366,693 |
58,394,116 |
RGD:6893372 |
RGD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
|
IED |
2 |
233,091,013 |
233,187,501 |
RGD:5135028 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
|
IEP |
19 |
37,251,147 |
37,266,040 |
RGD:5133249 |
RGD |
| G |
Otc |
ornithine carbamoyltransferase |
|
|
IEP |
X |
24,609,141 |
24,685,341 |
RGD:4144061 |
RGD |
| G |
Plin2 |
perilipin 2 |
|
|
ISS |
5 |
105,718,496 |
105,732,817 |
RGD:1625752 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
ISS |
7 |
123,729,774 |
123,807,090 |
RGD:5509939 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
IED |
4 |
151,492,220 |
151,617,331 |
RGD:1580685 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IEP |
14 |
64,278,115 |
64,370,912 |
RGD:7242179 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242012 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Treatment |
IED |
14 |
64,278,115 |
64,370,912 |
RGD:7241844 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
ISS |
2 |
54,327,821 |
54,360,462 |
RGD:6484544 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
ISS |
16 |
5,954,218 |
5,975,743 |
RGD:1642523 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
IEP |
1 |
236,771,027 |
236,837,261 |
RGD:2292522 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
1 |
236,771,027 |
236,837,261 |
RGD:1302555 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:5135028 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
IED |
1 |
208,262,669 |
208,273,148 |
RGD:5135028 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
ISS |
2 |
181,616,581 |
181,628,144 |
RGD:1642523 |
RGD |
| G |
Slc27a4 |
solute carrier family 27 (fatty acid transporter), member 4 |
|
|
IEP |
3 |
8,791,504 |
8,802,884 |
RGD:1625640 |
RGD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
Model |
IEP |
|
|
|
RGD:1598602 |
RGD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
ISS |
10 |
4,819,971 |
4,820,609 |
RGD:1625677 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
10 |
107,958,468 |
107,959,330 |
RGD:1625677 |
RGD |
| G |
Suox |
sulfite oxidase |
|
|
IEP |
7 |
1,973,471 |
1,976,040 |
RGD:1600114 |
RGD |
| G |
Txn1 |
thioredoxin 1 |
|
|
IEP |
5 |
75,921,365 |
75,933,595 |
RGD:2306156 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
IEP |
1 |
157,925,514 |
157,928,222 |
RGD:7204423 |
RGD |
| Q |
Hpcl2 |
Hepatic cholesterol level QTL 2 |
|
Susceptibility |
IAGP |
10 |
46,483,646 |
100,090,301 |
RGD:1643359 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SHR.BN-(D10Mgh3-D10Rat85)/Ipcv |
|
|
Resistance |
IED |
10 |
48,994,688 |
100,090,454 |
RGD:1643359 |
RGD |
| S |
SHR.BN-(D10Mgh3-Srebf1)/Ipcv |
|
|
Susceptibility |
IAGP |
10 |
46,461,684 |
100,090,454 |
RGD:1643359 |
RGD |
Fatty Liver, Alcoholic
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686674 |
RGD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
|
IED |
12 |
36,081,778 |
36,116,445 |
RGD:1599041 |
RGD |
| G |
Ctsb |
cathepsin B |
|
|
IEP |
15 |
42,402,829 |
42,423,701 |
RGD:2315516 |
RGD |
| G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
|
IEP |
|
|
|
RGD:1642369 |
RGD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
|
IEP |
10 |
62,713,441 |
62,739,444 |
RGD:2312349 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
IEP |
1 |
41,862,997 |
41,870,327 |
RGD:1625694 |
RGD |
Gastrinoma
|
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:7242847 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317354 |
RGD |
| G |
Met |
met proto-oncogene |
|
Severity |
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317605 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317340 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324977 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324976 |
RGD |
Glucagonoma
|
| G |
Btc |
betacellulin |
|
|
ISS |
14 |
18,194,470 |
18,235,228 |
RGD:2326087 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317288 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324977 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324976 |
RGD |
| G |
Sstr4 |
somatostatin receptor 4 |
|
|
ISS |
3 |
137,150,419 |
137,152,284 |
RGD:2324994 |
RGD |
Goldberg-Shprintzen megacolon syndrome
|
| G |
LOC606294 |
hypothetical protein LOC606294 |
|
|
ISS |
20 |
29,817,255 |
29,836,819 |
RGD:7240710 |
OMIM |
Hepatic Adenomas, Familial
|
| G |
Hnf1a |
HNF1 homeobox A |
|
|
ISS |
12 |
42,919,574 |
42,945,670 |
RGD:7240710 |
OMIM |
Hepatomegaly
|
| G |
Angptl4 |
angiopoietin-like 4 |
|
|
ISS |
7 |
16,261,623 |
16,267,852 |
RGD:1625354 |
RGD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
|
ISS |
6 |
10,203,108 |
10,297,215 |
RGD:734934 |
RGD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
|
IEP |
2 |
193,128,736 |
193,143,106 |
RGD:2326126 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
1 |
236,771,027 |
236,837,261 |
RGD:1302555 |
RGD |
Hereditary pancreatitis
|
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:7240710 |
OMIM |
| G |
Ctrc |
chymotrypsin C (caldecrin) |
|
|
ISS |
5 |
160,742,491 |
160,755,332 |
RGD:7240710 |
OMIM |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
|
ISS |
4 |
69,185,877 |
69,189,080 |
RGD:7240710 |
OMIM |
| G |
Prss2 |
protease, serine, 2 |
|
|
ISS |
4 |
69,088,288 |
69,093,312 |
RGD:7240710 |
OMIM |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
|
ISS |
18 |
37,090,934 |
37,099,835 |
RGD:7240710 |
OMIM |
Hirschsprung Disease
|
| G |
Ache |
acetylcholinesterase |
|
|
ISS |
|
|
|
RGD:5509847 |
RGD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
|
ISS |
7 |
120,223,788 |
120,266,944 |
RGD:1300344 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
IEP |
18 |
29,374,593 |
29,376,190 |
RGD:7193054 |
RGD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
|
ISS |
5 |
156,635,656 |
156,735,783 |
RGD:734909 |
RGD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
|
ISS |
5 |
156,635,656 |
156,735,783 |
RGD:7240710 |
OMIM |
| G |
Edn3 |
endothelin 3 |
|
|
ISS |
3 |
166,491,368 |
166,514,051 |
RGD:1601003 |
RGD |
| G |
Edn3 |
endothelin 3 |
|
|
ISS |
3 |
166,491,368 |
166,514,051 |
RGD:7240710 |
OMIM |
| G |
Ednrb |
endothelin receptor type B |
|
|
IAGP |
15 |
87,893,141 |
87,898,700 |
RGD:1342447 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
ISS |
15 |
87,893,141 |
87,898,700 |
RGD:1601008 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
ISS |
15 |
87,893,141 |
87,898,700 |
RGD:7240710 |
OMIM |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
10 |
87,219,157 |
87,242,919 |
RGD:734940 |
RGD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
|
ISS |
2 |
57,399,312 |
57,424,030 |
RGD:704404 |
RGD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
|
ISS |
2 |
57,399,312 |
57,424,030 |
RGD:7240710 |
OMIM |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
|
ISS |
1 |
264,614,329 |
264,875,486 |
RGD:6218967 |
RGD |
| G |
L1cam |
L1 cell adhesion molecule |
|
|
ISS |
X |
159,784,792 |
159,801,553 |
RGD:6483043 |
RGD |
| G |
Ngfr |
nerve growth factor receptor |
|
|
ISS |
10 |
84,262,804 |
84,281,006 |
RGD:5508387 |
RGD |
| G |
Nrtn |
neurturin |
|
|
ISS |
|
|
|
RGD:1600267 |
RGD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
|
ISS |
2 |
179,838,740 |
179,855,545 |
RGD:5684546 |
RGD |
| G |
Ret |
ret proto-oncogene |
|
|
ISS |
4 |
154,448,179 |
154,491,103 |
RGD:7240710 |
OMIM |
| G |
Stx1a |
syntaxin 1A (brain) |
|
|
ISS |
12 |
22,737,112 |
22,765,064 |
RGD:1581432 |
RGD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
|
ISS |
3 |
25,513,009 |
25,654,964 |
RGD:1599885 |
RGD |
| Q |
Gdil1 |
Gastrointestinal dilation QTL 1 |
|
|
IAGP |
2 |
57,161,998 |
75,806,439 |
RGD:6480217 |
RGD |
| S |
AR-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480215 |
RGD |
| S |
AR-EdnrbSlOkkm |
Aganglionosis rat |
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480215 |
RGD |
| S |
LE-EdnrbSlHkv |
Aganglionosis rat |
|
|
IED |
|
|
|
RGD:6480217 |
RGD |
| S |
LE.AR-EdnrbSl/Okkm |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
Sl |
|
|
Model |
IAGP |
|
|
|
RGD:1342447 |
RGD |
Hyperinsulinemic hypoglycemia, familial, 1
|
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:7240710 |
OMIM |
Hyperinsulinemic hypoglycemia, familial, 2
|
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:7240710 |
OMIM |
Insulinoma
|
| G |
Adm |
adrenomedullin |
|
|
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:2325319 |
RGD |
| G |
Btc |
betacellulin |
|
|
ISS |
14 |
18,194,470 |
18,235,228 |
RGD:2326087 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5491180 |
RGD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
|
ISS |
4 |
153,503,576 |
153,516,423 |
RGD:2317608 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317266 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317268 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
Disease_progression |
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317292 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317310 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317288 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
|
ISS |
8 |
52,822,350 |
53,120,572 |
RGD:2326080 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324976 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
2 |
116,036,501 |
116,065,834 |
RGD:2324977 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
4 |
120,355,649 |
120,437,772 |
RGD:2317472 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2325017 |
RGD |
| S |
DON |
Donryu rat |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
Intrahepatic cholangiocarcinoma
|
| G |
Asph |
aspartate-beta-hydroxylase |
|
|
ISS |
5 |
23,495,780 |
23,520,672 |
RGD:6902945 |
RGD |
Johanson Blizzard syndrome
|
| G |
Ubr1 |
ubiquitin protein ligase E3 component n-recognin 1 |
|
|
ISS |
3 |
107,632,668 |
107,746,611 |
RGD:7240710 |
OMIM |
Liver Cirrhosis, Biliary
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IEP |
10 |
95,361,338 |
95,381,455 |
RGD:2325226 |
RGD |
| G |
Aqp4 |
aquaporin 4 |
|
|
IEP |
18 |
6,626,313 |
6,642,766 |
RGD:5148030 |
RGD |
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (cirhin) |
|
|
ISS |
19 |
36,742,206 |
36,770,285 |
RGD:1600653 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314517 |
RGD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
Susceptibility |
ISS |
9 |
59,495,773 |
59,501,300 |
RGD:2301998 |
RGD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
|
IEP |
8 |
113,470,871 |
113,483,433 |
RGD:2314895 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:5509055 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
ISS |
18 |
32,371,496 |
32,459,145 |
RGD:4892607 |
RGD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
|
IPM |
2 |
219,410,394 |
219,550,910 |
RGD:2314466 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IEP |
14 |
64,278,115 |
64,370,912 |
RGD:6484526 |
RGD |
| G |
Ren |
renin |
|
|
IEP |
13 |
46,262,936 |
46,275,213 |
RGD:6892690 |
RGD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
|
IEP |
10 |
76,657,024 |
76,698,088 |
RGD:1642977 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:2317411 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
IEA |
7 |
136,567,614 |
136,617,280 |
RGD:1331525 |
RGD |
Liver Diseases
|
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
Susceptibility |
ISS |
12 |
36,081,778 |
36,116,445 |
RGD:1601162 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
IEP |
1 |
20,998,894 |
21,011,275 |
RGD:1599211 |
RGD |
| G |
Cpox |
coproporphyrinogen oxidase |
|
Susceptibility |
ISS |
11 |
42,748,703 |
42,758,686 |
RGD:1600955 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
No_Association |
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:4892218 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:4892216 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
IEP |
1 |
200,918,521 |
200,928,919 |
RGD:4892217 |
RGD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
|
ISS |
2 |
103,102,679 |
103,271,273 |
RGD:7240710 |
OMIM |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
|
IEP |
19 |
22,853,702 |
22,871,846 |
RGD:4891447 |
RGD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
|
IEP |
2 |
214,931,901 |
215,818,809 |
RGD:1599789 |
RGD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
|
ISS |
1 |
140,851,975 |
140,876,187 |
RGD:737742 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Susceptibility |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4142524 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889446 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
Onset |
IEP |
7 |
56,996,694 |
57,020,926 |
RGD:2317409 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
ISS |
1 |
95,027,197 |
95,032,516 |
RGD:6480869 |
RGD |
| G |
Prkcsh |
protein kinase C substrate 80K-H |
|
|
ISS |
8 |
21,107,041 |
21,144,270 |
RGD:1599188 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:4892128 |
RGD |
| G |
Thbd |
thrombomodulin |
|
|
ISS |
3 |
137,158,955 |
137,162,607 |
RGD:5684988 |
RGD |
| Q |
Hcuc1 |
Hepatic copper content QTL 1 |
|
|
IAGP |
|
|
|
RGD:619607 |
RGD |
| Q |
Hcuc2 |
Hepatic copper content QTL 2 |
|
|
IAGP |
16 |
1 |
40,096,622 |
RGD:619607 |
RGD |
| Q |
Hcuc3 |
Hepatic copper content QTL 3 |
|
|
IAGP |
2 |
217,985,582 |
238,139,978 |
RGD:629572 |
RGD |
| Q |
Hcuc4 |
Hepatic copper content QTL 4 |
|
|
IAGP |
10 |
70,191,595 |
77,091,834 |
RGD:629572 |
RGD |
| S |
WF.LEW-RVFV |
|
|
Resistance |
TAS |
|
|
|
RGD:2292456 |
RGD |
Liver Neoplasms
|
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
|
IEP |
5 |
66,283,165 |
66,296,171 |
RGD:2313432 |
RGD |
| G |
Hspa4 |
heat shock protein 4 |
|
|
IEP |
10 |
38,705,629 |
38,749,058 |
RGD:5686872 |
RGD |
| G |
Met |
met proto-oncogene |
|
Onset |
IEP |
4 |
43,134,183 |
43,211,355 |
RGD:2317546 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Onset |
IEP |
5 |
165,112,850 |
165,126,885 |
RGD:6893663 |
RGD |
| G |
Ttpa |
tocopherol (alpha) transfer protein |
|
|
IEP |
5 |
34,638,551 |
34,659,077 |
RGD:1600436 |
RGD |
| Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
|
IED |
7 |
38,076,588 |
83,076,588 |
RGD:629574 |
RGD |
| Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
|
IED |
1 |
241,199,027 |
267,910,886 |
RGD:629574 |
RGD |
| Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
|
IAGP |
2 |
1 |
41,032,214 |
RGD:737884 |
RGD |
| Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
|
IAGP |
13 |
1 |
43,835,207 |
RGD:737884 |
RGD |
| Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
|
IAGP |
13 |
62,072,299 |
94,306,205 |
RGD:737884 |
RGD |
| Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
|
IAGP |
13 |
78,189,125 |
111,154,910 |
RGD:737884 |
RGD |
| S |
DRH/Seac |
|
|
|
IED |
|
|
|
RGD:625382 |
RGD |
Liver Neoplasms, Experimental
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
|
IED |
|
|
|
RGD:1598580 |
RGD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
|
IEP |
4 |
21,829,489 |
21,912,239 |
RGD:5684351 |
RGD |
| G |
Adsl |
adenylosuccinate lyase |
|
|
IEP |
7 |
119,223,582 |
119,248,151 |
RGD:1598766 |
RGD |
| G |
Agps |
alkylglycerone phosphate synthase |
|
|
IED |
|
|
|
RGD:1598794 |
RGD |
| G |
Arrb2 |
arrestin, beta 2 |
|
|
IEP |
10 |
57,244,071 |
57,284,166 |
RGD:5509890 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
IEP |
|
|
|
RGD:2293125 |
RGD |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
|
IEP |
6 |
25,272,416 |
25,296,266 |
RGD:5132586 |
RGD |
| G |
Ccnb1 |
cyclin B1 |
|
|
IEP |
2 |
31,574,600 |
31,581,784 |
RGD:2315991 |
RGD |
| G |
Ccnd1 |
cyclin D1 |
|
|
IEP |
1 |
205,357,235 |
205,366,757 |
RGD:2289139 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISS |
X |
141,925,019 |
141,937,183 |
RGD:5491179 |
RGD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
Severity |
IEP |
9 |
65,907,211 |
66,017,942 |
RGD:2303406 |
RGD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
|
IEP |
19 |
39,463,111 |
39,477,184 |
RGD:5132618 |
RGD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
|
IEP |
9 |
93,065,333 |
93,074,168 |
RGD:5133686 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
IEP |
1 |
206,627,398 |
206,629,866 |
RGD:2317823 |
RGD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
|
IED |
1 |
202,822,925 |
202,825,601 |
RGD:1342455 |
RGD |
| G |
Hat1 |
histone acetyltransferase 1 |
|
|
IEP |
3 |
53,696,664 |
53,744,333 |
RGD:2316578 |
RGD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
|
IEP |
X |
31,012,921 |
31,244,127 |
RGD:1624998 |
RGD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
|
IAGP |
1 |
42,253,273 |
42,341,646 |
RGD:2311623 |
RGD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
|
IAGP |
1 |
42,253,273 |
42,341,646 |
RGD:2311630 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
IEP |
8 |
68,379,074 |
68,451,554 |
RGD:2306052 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
IEP |
19 |
15,246,036 |
15,275,061 |
RGD:2325736 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
IEP |
19 |
15,246,036 |
15,275,061 |
RGD:2325734 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:2325734 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:2325736 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:2325277 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
IEP |
3 |
4,631,797 |
4,677,640 |
RGD:2325310 |
RGD |
| G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
|
IEP |
|
|
|
RGD:1642378 |
RGD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
|
IEP |
3 |
105,625,265 |
105,650,392 |
RGD:2292638 |
RGD |
| G |
Rrm1 |
ribonucleotide reductase M1 |
|
|
IEP |
|
|
|
RGD:2316863 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
|
IEP |
3 |
6,605,782 |
6,689,224 |
RGD:1643105 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
IEP |
6 |
127,998,617 |
128,021,719 |
RGD:1626391 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
IEP |
4 |
120,355,649 |
120,437,772 |
RGD:2317490 |
RGD |
| G |
Vim |
vimentin |
|
|
IED |
17 |
87,847,280 |
87,855,763 |
RGD:6480440 |
RGD |
| Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
|
IED |
10 |
6,172,805 |
36,254,741 |
RGD:619598 |
RGD |
| Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
|
IED |
8 |
43,313,902 |
87,122,960 |
RGD:629566 |
RGD |
| Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
|
IED |
6 |
41,300,997 |
115,238,799 |
RGD:629566 |
RGD |
| Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
|
IED |
3 |
25,775,548 |
118,863,223 |
RGD:629566 |
RGD |
| Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
|
IED |
4 |
1 |
29,414,068 |
RGD:737884 |
RGD |
| Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
|
IED |
18 |
53,847,682 |
86,863,412 |
RGD:737884 |
RGD |
| Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
|
IED |
1 |
156,124,624 |
247,322,277 |
RGD:1358145 |
RGD |
| Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
|
IED |
4 |
78,035,196 |
135,074,488 |
RGD:619598 |
RGD |
| Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
|
IED |
8 |
57,308,572 |
103,684,785 |
RGD:619598 |
RGD |
| Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
|
IED |
1 |
198,396,580 |
220,639,653 |
RGD:619609 |
RGD |
| Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
|
IED |
1 |
220,639,539 |
232,579,992 |
RGD:619609 |
RGD |
| Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
|
IED |
1 |
224,822,211 |
267,910,886 |
RGD:619609 |
RGD |
| Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
|
IED |
4 |
58,550,170 |
93,498,821 |
RGD:619609 |
RGD |
| Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
|
IED |
|
|
|
RGD:619609 |
RGD |
| Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
|
IED |
4 |
106,554,769 |
171,204,531 |
RGD:629566 |
RGD |
| Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
|
IED |
7 |
96,649,133 |
137,404,381 |
RGD:619598 |
RGD |
| Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
|
IED |
1 |
6,253,946 |
116,153,262 |
RGD:619598 |
RGD |
| Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
|
IED |
1 |
146,971,846 |
228,781,113 |
RGD:629566 |
RGD |
| Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
|
IED |
16 |
4,304,396 |
50,266,190 |
RGD:629566 |
RGD |
| Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
|
IED |
1 |
180,678,929 |
265,343,617 |
RGD:737884 |
RGD |
| Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
|
IED |
14 |
41,608,939 |
89,192,873 |
RGD:737884 |
RGD |
| Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
|
IED |
15 |
2,306,220 |
43,057,384 |
RGD:737884 |
RGD |
| Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
|
IED |
16 |
1 |
24,132,402 |
RGD:1599590 |
RGD |
| S |
ACI/N |
A X C 9935, Irish |
|
Model |
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
DRH/Seac |
|
|
Resistance |
TAS |
|
|
|
RGD:625382 |
RGD |
Melanoma-Pancreatic Cancer Syndrome
|
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
5 |
108,908,749 |
108,916,380 |
RGD:7240710 |
OMIM |
Microphthalmia, Syndromic 3
|
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
|
ISS |
2 |
120,969,021 |
120,971,430 |
RGD:7240710 |
OMIM |
Mowat-Wilson syndrome
|
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
|
ISS |
3 |
25,513,009 |
25,654,964 |
RGD:7240710 |
OMIM |
Non-alcoholic Fatty Liver Disease
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
IEP |
11 |
79,908,291 |
79,911,065 |
RGD:5686355 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
Disease_progression |
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686810 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686660 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
IEP |
11 |
79,908,291 |
79,911,065 |
RGD:5685373 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686841 |
RGD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
|
ISS |
10 |
57,185,939 |
57,194,388 |
RGD:5509622 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IED |
1 |
79,003,634 |
79,006,387 |
RGD:6904141 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISS |
4 |
13,471,878 |
13,525,620 |
RGD:6893543 |
RGD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
|
IEP |
2 |
27,127,504 |
27,149,580 |
RGD:5508690 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IEP |
9 |
81,585,251 |
81,638,071 |
RGD:6483014 |
RGD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
IEP |
16 |
83,379,987 |
83,404,220 |
RGD:6483014 |
RGD |
| G |
Jak2 |
Janus kinase 2 |
|
|
IED |
1 |
232,915,995 |
232,974,763 |
RGD:6483030 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:5509578 |
RGD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
|
ISS |
9 |
13,057,988 |
13,100,289 |
RGD:6482771 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IED |
14 |
64,278,115 |
64,370,912 |
RGD:6484527 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
Susceptibility |
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7241847 |
RGD |
| G |
Retn |
resistin |
|
|
IEP |
12 |
2,499,630 |
2,501,370 |
RGD:7207249 |
RGD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
|
IED |
10 |
89,821,078 |
89,872,970 |
RGD:6483030 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
Treatment |
IED |
1 |
157,925,514 |
157,928,222 |
RGD:7175312 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
IEP |
1 |
157,925,514 |
157,928,222 |
RGD:7204434 |
RGD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
|
ISS |
1 |
157,925,514 |
157,928,222 |
RGD:7204435 |
RGD |
North American Indian Childhood Cirrhosis
|
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (cirhin) |
|
|
ISS |
19 |
36,742,206 |
36,770,285 |
RGD:7240710 |
OMIM |
Opitz-Kaveggia syndrome
|
| G |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
|
ISS |
X |
20,910,960 |
21,250,869 |
RGD:7240710 |
OMIM |
| G |
Med12 |
mediator complex subunit 12 |
|
|
ISS |
X |
89,351,546 |
89,374,489 |
RGD:7240710 |
OMIM |
Pancreatic carcinoma, familial
|
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISS |
8 |
49,233,142 |
49,233,431 |
RGD:5685662 |
RGD |
Pancreatic Diseases
|
| G |
Gip |
gastric inhibitory polypeptide |
|
|
IEP |
10 |
84,732,705 |
84,740,801 |
RGD:2312553 |
RGD |
| G |
Hnf1b |
HNF1 homeobox B |
|
|
ISS |
10 |
72,081,091 |
72,187,014 |
RGD:2312751 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:2307287 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326052 |
RGD |
Pancreatic Neoplasms
|
| G |
A4gnt |
alpha-1,4-N-acetylglucosaminyltransferase |
|
|
ISS |
8 |
104,476,664 |
104,491,166 |
RGD:2325199 |
RGD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
|
ISS |
|
|
|
RGD:2317509 |
RGD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
Severity |
ISS |
10 |
82,986,552 |
83,030,799 |
RGD:2325200 |
RGD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
|
ISS |
11 |
82,714,334 |
82,809,354 |
RGD:2325200 |
RGD |
| G |
Abo |
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) |
|
|
ISS |
3 |
5,730,553 |
5,751,204 |
RGD:2317511 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:2325208 |
RGD |
| G |
Acvr1 |
activin A receptor, type I |
|
|
ISS |
3 |
40,191,727 |
40,260,488 |
RGD:2317217 |
RGD |
| G |
Acvr1b |
activin A receptor, type IB |
|
|
ISS |
7 |
139,910,157 |
139,958,740 |
RGD:2317217 |
RGD |
| G |
Acvr1b |
activin A receptor, type IB |
|
|
ISS |
7 |
139,910,157 |
139,958,740 |
RGD:1598735 |
RGD |
| G |
Acvr2a |
activin A receptor, type IIA |
|
|
ISS |
3 |
29,779,827 |
29,808,881 |
RGD:2317217 |
RGD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
|
ISS |
2 |
181,527,175 |
181,537,640 |
RGD:2325247 |
RGD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
|
ISS |
16 |
71,446,498 |
71,526,108 |
RGD:2325247 |
RGD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
|
ISS |
2 |
235,799,396 |
235,811,584 |
RGD:2325313 |
RGD |
| G |
Adm |
adrenomedullin |
|
Disease_progression |
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:2325317 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:2325318 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:2325643 |
RGD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
ISS |
|
|
|
RGD:2325641 |
RGD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
|
ISS |
6 |
54,205,104 |
54,240,268 |
RGD:2325664 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:2290476 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISS |
1 |
82,686,233 |
82,726,544 |
RGD:5490965 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
14 |
19,126,935 |
19,142,214 |
RGD:2325678 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
14 |
19,126,935 |
19,142,214 |
RGD:2325675 |
RGD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
|
ISS |
1 |
223,731,675 |
223,773,285 |
RGD:2325688 |
RGD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
Susceptibility |
ISS |
12 |
36,081,778 |
36,116,445 |
RGD:2325694 |
RGD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
Susceptibility |
ISS |
12 |
36,081,778 |
36,116,445 |
RGD:2325313 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:2317524 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:2317523 |
RGD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
Disease_progression |
ISS |
15 |
27,083,089 |
27,083,526 |
RGD:2325716 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
ISS |
1 |
223,478,436 |
223,494,455 |
RGD:2325722 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
ISS |
1 |
223,478,436 |
223,494,455 |
RGD:2325723 |
RGD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
|
ISS |
7 |
27,932,908 |
28,020,533 |
RGD:2325739 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:2317208 |
RGD |
| G |
Apc |
adenomatous polyposis coli |
|
|
ISS |
18 |
26,732,147 |
26,790,383 |
RGD:2317207 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISS |
|
|
|
RGD:2325757 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISS |
|
|
|
RGD:2325758 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IEP |
1 |
79,003,634 |
79,006,387 |
RGD:2317552 |
RGD |
| G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
|
|
ISS |
|
|
|
RGD:2317557 |
RGD |
| G |
Artn |
artemin |
|
|
ISS |
5 |
138,390,981 |
138,394,250 |
RGD:2325815 |
RGD |
| G |
Artn |
artemin |
|
Disease_progression |
ISS |
5 |
138,390,981 |
138,394,250 |
RGD:2325817 |
RGD |
| G |
Atm |
ataxia telangiectasia mutated |
|
|
ISS |
8 |
56,894,746 |
56,996,565 |
RGD:2317367 |
RGD |
| G |
Atm |
ataxia telangiectasia mutated |
|
|
ISS |
8 |
56,894,746 |
56,996,565 |
RGD:2317234 |
RGD |
| G |
Atm |
ataxia telangiectasia mutated |
|
Susceptibility |
ISS |
8 |
56,894,746 |
56,996,565 |
RGD:2317363 |
RGD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
|
ISS |
8 |
100,936,342 |
101,014,881 |
RGD:2317234 |
RGD |
| G |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
|
|
ISS |
11 |
36,580,436 |
36,641,598 |
RGD:2317558 |
RGD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
|
ISS |
1 |
187,781,147 |
187,804,835 |
RGD:2325843 |
RGD |
| G |
Bag4 |
BCL2-associated athanogene 4 |
|
|
ISS |
16 |
70,663,821 |
70,680,671 |
RGD:2325852 |
RGD |
| G |
Bid |
BH3 interacting domain death agonist |
|
|
ISS |
4 |
157,296,383 |
157,318,481 |
RGD:2317560 |
RGD |
| G |
Boc |
BOC cell adhesion associated, oncogene regulated |
|
|
ISS |
11 |
57,668,326 |
57,710,373 |
RGD:5490966 |
RGD |
| G |
Brca2 |
breast cancer 2, early onset |
|
|
ISS |
12 |
4,282,952 |
4,323,693 |
RGD:7240710 |
OMIM |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
|
ISS |
3 |
105,063,018 |
105,116,145 |
RGD:2326105 |
RGD |
| G |
Cacybp |
calcyclin binding protein |
|
Disease_progression |
ISS |
13 |
75,623,161 |
75,633,644 |
RGD:2326146 |
RGD |
| G |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
|
Disease_progression |
ISS |
5 |
142,174,441 |
142,201,120 |
RGD:2326238 |
RGD |
| G |
Capn10 |
calpain 10 |
|
Susceptibility |
ISS |
|
|
|
RGD:4107073 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:2317230 |
RGD |
| G |
Casp8 |
caspase 8 |
|
Susceptibility |
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:2315744 |
RGD |
| G |
Cat |
catalase |
|
Disease_progression |
ISS |
3 |
88,654,077 |
88,686,212 |
RGD:2317410 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
IEP |
14 |
62,052,510 |
62,057,201 |
RGD:4110822 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
14 |
62,052,510 |
62,057,201 |
RGD:4110817 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
IED |
1 |
163,156,914 |
163,166,969 |
RGD:4110821 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
Susceptibility |
ISS |
1 |
163,156,914 |
163,166,969 |
RGD:4110829 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
Disease_progression |
IEP |
1 |
163,156,914 |
163,166,969 |
RGD:4110823 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
IEP |
1 |
163,156,914 |
163,166,969 |
RGD:4110822 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2317567 |
RGD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
|
ISS |
8 |
118,883,148 |
118,884,230 |
RGD:2317610 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:2317567 |
RGD |
| G |
Cd97 |
CD97 molecule |
|
|
ISS |
19 |
26,089,268 |
26,108,997 |
RGD:2317573 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
No_Association |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:2317157 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Onset |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:2317156 |
RGD |
| G |
Chek1 |
checkpoint kinase 1 |
|
Disease_progression |
ISS |
8 |
37,954,322 |
37,974,748 |
RGD:2317234 |
RGD |
| G |
Cldn4 |
claudin 4 |
|
|
ISS |
12 |
22,816,134 |
22,817,932 |
RGD:2317583 |
RGD |
| G |
Cldn4 |
claudin 4 |
|
|
ISS |
12 |
22,816,134 |
22,817,932 |
RGD:2317580 |
RGD |
| G |
Cycs |
cytochrome c, somatic |
|
|
ISS |
4 |
78,825,878 |
78,827,978 |
RGD:2317614 |
RGD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
Susceptibility |
ISS |
1 |
251,965,458 |
251,971,449 |
RGD:2317618 |
RGD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
|
ISS |
2 |
214,931,901 |
215,818,809 |
RGD:2317630 |
RGD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
Disease_progression |
ISS |
2 |
214,931,901 |
215,818,809 |
RGD:2317629 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:5490965 |
RGD |
| G |
Egf |
epidermal growth factor |
|
Disease_progression |
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:2317650 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5490965 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131631 |
RGD |
| G |
Epha3 |
Eph receptor A3 |
|
|
ISS |
11 |
696,185 |
1,033,287 |
RGD:2317720 |
RGD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
|
ISS |
|
|
|
RGD:2317223 |
RGD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
|
ISS |
|
|
|
RGD:2317228 |
RGD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
|
ISS |
10 |
2,144,262 |
2,177,554 |
RGD:2317223 |
RGD |
| G |
Fanca |
Fanconi anemia, complementation group A |
|
|
ISS |
19 |
53,587,849 |
53,647,780 |
RGD:2317735 |
RGD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
|
ISS |
17 |
7,254,528 |
7,341,500 |
RGD:2317239 |
RGD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
|
ISS |
17 |
7,254,528 |
7,341,500 |
RGD:2317238 |
RGD |
| G |
Fancg |
Fanconi anemia, complementation group G |
|
|
ISS |
5 |
59,494,640 |
59,501,785 |
RGD:2317238 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317745 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
Resistance |
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2315744 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
Severity |
ISS |
13 |
77,472,950 |
77,480,210 |
RGD:2317744 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317762 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317760 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317759 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2317765 |
RGD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
Severity |
ISS |
|
|
|
RGD:2317785 |
RGD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
Severity |
ISS |
2 |
57,399,312 |
57,424,030 |
RGD:2324925 |
RGD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
|
ISS |
7 |
67,288,291 |
67,297,461 |
RGD:5491005 |
RGD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
|
ISS |
7 |
67,288,291 |
67,297,461 |
RGD:5490966 |
RGD |
| G |
Gli3 |
GLI family zinc finger 3 |
|
|
ISS |
17 |
57,594,102 |
57,867,710 |
RGD:5490966 |
RGD |
| G |
Gnas |
GNAS complex locus |
|
|
ISS |
3 |
165,213,399 |
165,214,551 |
RGD:2317256 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317805 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Susceptibility |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:2317804 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
4 |
14,864,357 |
14,932,513 |
RGD:2317895 |
RGD |
| G |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
|
|
ISS |
1 |
180,202,791 |
180,324,718 |
RGD:2317633 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2325165 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISS |
7 |
57,621,756 |
57,625,792 |
RGD:2317258 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
Susceptibility |
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2306689 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317651 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317640 |
RGD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
ISS |
1 |
122,704,976 |
122,990,007 |
RGD:2317642 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Susceptibility |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2317653 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:2317655 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:2317670 |
RGD |
| G |
Il13 |
interleukin 13 |
|
Disease_progression |
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:2317669 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:2311069 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:2317657 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:2311069 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Susceptibility |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:2317215 |
RGD |
| G |
Il3 |
interleukin 3 |
|
|
ISS |
10 |
39,684,691 |
39,687,041 |
RGD:2317663 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:2317267 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:2317265 |
RGD |
| G |
Il4 |
interleukin 4 |
|
Disease_progression |
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:2317261 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
Disease_progression |
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:2317669 |
RGD |
| G |
Ins2 |
insulin 2 |
|
Susceptibility |
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317250 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317245 |
RGD |
| G |
Ins2 |
insulin 2 |
|
Susceptibility |
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317247 |
RGD |
| G |
Ins2 |
insulin 2 |
|
Disease_progression |
ISS |
1 |
202,935,548 |
202,936,379 |
RGD:2317253 |
RGD |
| G |
Kdr |
kinase insert domain receptor |
|
|
ISS |
|
|
|
RGD:5684397 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
Disease_progression |
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:1581761 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5490965 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5490966 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:7240710 |
OMIM |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
Resistance |
ISS |
10 |
71,000,287 |
71,021,398 |
RGD:2317363 |
RGD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
Susceptibility |
ISS |
16 |
84,881,880 |
84,888,448 |
RGD:2317363 |
RGD |
| G |
LOC100360205 |
palladin |
|
|
ISS |
16 |
31,854,459 |
31,933,792 |
RGD:7240710 |
OMIM |
| G |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
|
|
ISS |
3 |
51,563,764 |
51,724,478 |
RGD:5490966 |
RGD |
| G |
Lum |
lumican |
|
Disease_progression |
ISS |
7 |
35,083,480 |
35,090,284 |
RGD:2317682 |
RGD |
| G |
Lum |
lumican |
|
Disease_progression |
ISS |
7 |
35,083,480 |
35,090,284 |
RGD:2317230 |
RGD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
|
ISS |
8 |
112,111,358 |
112,113,311 |
RGD:2325804 |
RGD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
No_Association |
ISS |
8 |
112,111,358 |
112,113,311 |
RGD:2317157 |
RGD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
|
ISS |
10 |
52,009,149 |
52,041,599 |
RGD:5490966 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISS |
1 |
209,114,987 |
209,120,837 |
RGD:2317340 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:5490965 |
RGD |
| G |
Met |
met proto-oncogene |
|
Severity |
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317235 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
IEP |
4 |
43,134,183 |
43,211,355 |
RGD:2317613 |
RGD |
| G |
Mgat4a |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
|
|
ISS |
9 |
36,384,072 |
36,477,938 |
RGD:2317701 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
1 |
196,629,366 |
196,866,937 |
RGD:2317628 |
RGD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
Disease_progression |
ISS |
1 |
195,310,027 |
195,336,224 |
RGD:2317703 |
RGD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
|
ISS |
1 |
195,310,027 |
195,336,224 |
RGD:2317704 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:2325766 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:2325752 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325849 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325766 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325854 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
Disease_progression |
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:2325831 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
Resistance |
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:2317406 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326060 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326052 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326056 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
10 |
15,017,162 |
15,022,823 |
RGD:2326062 |
RGD |
| G |
Mtap |
methylthioadenosine phosphorylase |
|
|
ISS |
5 |
108,788,725 |
108,861,905 |
RGD:2317952 |
RGD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Susceptibility |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:2317120 |
RGD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
Susceptibility |
ISS |
17 |
68,782,708 |
68,867,101 |
RGD:2317118 |
RGD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
No_Association |
ISS |
17 |
68,782,708 |
68,867,101 |
RGD:2317120 |
RGD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
|
ISS |
17 |
5,086,219 |
5,118,086 |
RGD:2317118 |
RGD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
Susceptibility |
ISS |
17 |
5,086,219 |
5,118,086 |
RGD:2325772 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2317987 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324635 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Disease_progression |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2317984 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324622 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324637 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:2324639 |
RGD |
| G |
Muc16 |
mucin 16, cell surface associated |
|
|
ISS |
8 |
16,552,167 |
16,726,561 |
RGD:2325129 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324931 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324914 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
Disease_progression |
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324923 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324922 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:2324891 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
|
ISS |
|
|
|
RGD:2325129 |
RGD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
|
ISS |
|
|
|
RGD:2317984 |
RGD |
| G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
|
ISS |
1 |
201,815,833 |
201,837,239 |
RGD:2325167 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
7 |
98,953,142 |
98,958,060 |
RGD:7240699 |
RGD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
|
ISS |
16 |
23,845,894 |
23,876,528 |
RGD:2317170 |
RGD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
Susceptibility |
ISS |
16 |
23,845,894 |
23,876,528 |
RGD:2317168 |
RGD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
Susceptibility |
ISS |
16 |
23,855,555 |
23,876,531 |
RGD:2317169 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
Disease_progression |
ISS |
8 |
52,822,350 |
53,120,572 |
RGD:2326074 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
Severity |
ISS |
8 |
52,822,350 |
53,120,572 |
RGD:2326075 |
RGD |
| G |
Ngfr |
nerve growth factor receptor |
|
Severity |
ISS |
10 |
84,262,804 |
84,281,006 |
RGD:5508229 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
Disease_progression |
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2325262 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2325248 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
Disease_progression |
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:2325257 |
RGD |
| G |
Notch1 |
notch 1 |
|
Disease_progression |
ISS |
3 |
4,631,797 |
4,677,640 |
RGD:2325328 |
RGD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
Severity |
ISS |
2 |
179,838,740 |
179,855,545 |
RGD:5508229 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
ISS |
1 |
133,925,530 |
134,302,139 |
RGD:2325656 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
Disease_progression |
ISS |
4 |
149,209,745 |
149,219,081 |
RGD:2317132 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
|
ISS |
4 |
149,209,745 |
149,219,081 |
RGD:2317130 |
RGD |
| G |
Palb2 |
partner and localizer of BRCA2 |
|
Susceptibility |
ISS |
1 |
180,928,710 |
180,952,518 |
RGD:2325776 |
RGD |
| G |
Palb2 |
partner and localizer of BRCA2 |
|
|
ISS |
1 |
180,928,710 |
180,952,518 |
RGD:7240710 |
OMIM |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
|
ISS |
16 |
31,144,028 |
31,144,544 |
RGD:2325782 |
RGD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
|
ISS |
16 |
31,144,028 |
31,144,544 |
RGD:2325779 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISS |
14 |
35,369,422 |
35,418,126 |
RGD:2324851 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISS |
14 |
35,369,422 |
35,418,126 |
RGD:2324850 |
RGD |
| G |
Pfn1 |
profilin 1 |
|
|
ISS |
10 |
57,531,661 |
57,534,366 |
RGD:2317552 |
RGD |
| G |
Polb |
polymerase (DNA directed), beta |
|
Disease_progression |
ISS |
16 |
73,864,702 |
73,888,011 |
RGD:2317132 |
RGD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
Disease_progression |
ISS |
20 |
6,479,108 |
6,544,255 |
RGD:2324872 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
Susceptibility |
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2317460 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
ISS |
4 |
151,492,220 |
151,617,331 |
RGD:2317462 |
RGD |
| G |
Ptch1 |
patched 1 |
|
|
ISS |
17 |
7,088,234 |
7,142,459 |
RGD:2324910 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
1 |
236,771,027 |
236,837,261 |
RGD:5490965 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Susceptibility |
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135527 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:2317179 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Susceptibility |
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:2317184 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:2317175 |
RGD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
|
ISS |
|
|
|
RGD:2317365 |
RGD |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
|
ISS |
4 |
179,927,255 |
179,951,742 |
RGD:2317370 |
RGD |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
|
ISS |
4 |
179,927,255 |
179,951,742 |
RGD:2317365 |
RGD |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
|
ISS |
4 |
179,927,255 |
179,951,742 |
RGD:2317369 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
ISS |
1 |
208,262,669 |
208,273,148 |
RGD:2298892 |
RGD |
| G |
Ret |
ret proto-oncogene |
|
Disease_progression |
ISS |
4 |
154,448,179 |
154,491,103 |
RGD:2324926 |
RGD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
|
ISS |
6 |
42,350,541 |
42,356,748 |
RGD:2324950 |
RGD |
| G |
Runx3 |
runt-related transcription factor 3 |
|
Disease_progression |
ISS |
5 |
153,950,116 |
153,973,141 |
RGD:2324956 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
|
ISS |
3 |
6,605,782 |
6,689,224 |
RGD:2317462 |
RGD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
|
ISS |
6 |
115,431,169 |
115,472,901 |
RGD:2317190 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
Disease_progression |
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:2324960 |
RGD |
| G |
Shh |
sonic hedgehog |
|
|
ISS |
4 |
2,200,504 |
2,209,657 |
RGD:5490965 |
RGD |
| G |
Smo |
smoothened, frizzled family receptor |
|
|
ISS |
4 |
56,623,494 |
56,645,571 |
RGD:2324978 |
RGD |
| G |
Smo |
smoothened, frizzled family receptor |
|
|
ISS |
4 |
56,623,494 |
56,645,571 |
RGD:2324910 |
RGD |
| G |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
|
|
ISS |
12 |
9,950,304 |
10,042,391 |
RGD:2302550 |
RGD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
|
ISS |
16 |
10,025,978 |
10,030,516 |
RGD:6478801 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:2317410 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:1581235 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
Susceptibility |
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:2317406 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
Disease_progression |
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:2317410 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581363 |
RGD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
|
ISS |
7 |
11,086,760 |
11,103,522 |
RGD:7240710 |
OMIM |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
4 |
120,355,649 |
120,437,772 |
RGD:5490965 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
IPM |
4 |
120,355,649 |
120,437,772 |
RGD:2317468 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
4 |
120,355,649 |
120,437,772 |
RGD:2317473 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2325018 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:2325015 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
Disease_progression |
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317502 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317501 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
8 |
120,593,595 |
120,680,453 |
RGD:2317499 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
Disease_progression |
ISS |
|
|
|
RGD:2325021 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
|
|
|
RGD:2325028 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
|
|
|
RGD:2325023 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISS |
10 |
56,399,721 |
56,411,150 |
RGD:5490966 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISS |
10 |
56,399,721 |
56,411,150 |
RGD:7240710 |
OMIM |
| G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
|
|
ISS |
3 |
107,994,425 |
108,071,133 |
RGD:2325154 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
|
ISS |
7 |
127,666,518 |
127,671,624 |
RGD:2325156 |
RGD |
| G |
Uck2 |
uridine-cytidine kinase 2 |
|
|
ISS |
13 |
82,892,893 |
82,949,575 |
RGD:5133269 |
RGD |
| G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
|
ISS |
9 |
87,029,500 |
87,098,362 |
RGD:2317503 |
RGD |
| G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
No_Association |
ISS |
9 |
87,029,500 |
87,098,362 |
RGD:2317157 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:2325162 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
|
ISS |
4 |
149,529,396 |
149,536,289 |
RGD:2325169 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
|
ISS |
4 |
149,529,396 |
149,536,289 |
RGD:2325176 |
RGD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
|
ISS |
4 |
125,672,674 |
125,699,925 |
RGD:2317130 |
RGD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
|
ISS |
1 |
79,834,167 |
79,860,300 |
RGD:2317367 |
RGD |
| G |
Xrcc2 |
X-ray repair complementing defective repair in Chinese hamster cells 2 |
|
|
ISS |
4 |
4,817,222 |
4,835,725 |
RGD:2317507 |
RGD |
| G |
Xrcc2 |
X-ray repair complementing defective repair in Chinese hamster cells 2 |
|
|
ISS |
4 |
4,817,222 |
4,835,725 |
RGD:2317365 |
RGD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
|
ISS |
6 |
136,594,276 |
136,602,069 |
RGD:2317130 |
RGD |
Pancreatitis
|
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
|
IPM |
6 |
129,744,781 |
129,748,851 |
RGD:4891025 |
RGD |
| G |
Casp12 |
caspase 12 |
|
|
IEP |
8 |
2,082,933 |
2,110,511 |
RGD:2311467 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
IEP |
16 |
48,944,226 |
48,962,420 |
RGD:2311467 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2307002 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IPM |
10 |
70,256,263 |
70,258,061 |
RGD:2307046 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:2317568 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
IEP |
10 |
71,605,791 |
71,610,330 |
RGD:2307146 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144143 |
RGD |
| G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
|
IEP |
5 |
154,674,754 |
154,702,552 |
RGD:2316197 |
RGD |
| G |
Ctrb1 |
chymotrypsinogen B1 |
|
|
IEP |
19 |
41,611,382 |
41,616,058 |
RGD:2303363 |
RGD |
| G |
Ctsl1 |
cathepsin L1 |
|
|
IEP |
17 |
6,288,013 |
6,294,174 |
RGD:2315546 |
RGD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
|
IEP |
10 |
16,942,913 |
16,945,696 |
RGD:2301725 |
RGD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
|
IEP |
13 |
100,022,421 |
100,059,539 |
RGD:2301725 |
RGD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
|
IEP |
16 |
61,109,626 |
61,119,981 |
RGD:2301725 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:2317638 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
IEP |
18 |
27,343,919 |
27,346,117 |
RGD:5131939 |
RGD |
| G |
Fdx1 |
ferredoxin 1 |
|
|
IEP |
8 |
55,291,396 |
55,310,507 |
RGD:4145666 |
RGD |
| G |
Fga |
fibrinogen alpha chain |
|
|
IEP |
2 |
174,737,640 |
174,753,598 |
RGD:5688770 |
RGD |
| G |
Fgb |
fibrinogen beta chain |
|
|
IEP |
2 |
174,768,193 |
174,775,102 |
RGD:5688770 |
RGD |
| G |
Fgg |
fibrinogen gamma chain |
|
|
IEP |
2 |
174,727,312 |
174,734,594 |
RGD:5688770 |
RGD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
|
IEP |
9 |
11,033,496 |
11,038,868 |
RGD:5686868 |
RGD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
|
IED |
15 |
55,463,743 |
55,532,293 |
RGD:1624393 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:2325163 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
IEP |
13 |
43,953,900 |
43,957,766 |
RGD:2306925 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
IEP |
10 |
39,093,512 |
39,096,069 |
RGD:4145466 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145466 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
IED |
19 |
27,487,268 |
27,498,973 |
RGD:4892671 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
IEP |
8 |
53,936,584 |
53,943,228 |
RGD:4889404 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IED |
3 |
116,964,422 |
116,970,867 |
RGD:7204440 |
RGD |
| G |
Itgb2 |
integrin, beta 2 |
|
|
ISS |
20 |
11,446,521 |
11,485,009 |
RGD:6482196 |
RGD |
| G |
Klk1 |
kallikrein 1 |
|
|
IEP |
1 |
94,624,828 |
94,628,822 |
RGD:1641805 |
RGD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
|
IEP |
7 |
56,996,694 |
57,020,926 |
RGD:2317361 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
IEP |
4 |
43,134,183 |
43,211,355 |
RGD:2317606 |
RGD |
| G |
Mt-atp8 |
mitochondrially encoded ATP synthase 8 |
|
Susceptibility |
ISS |
MT |
7,758 |
7,961 |
RGD:5490297 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IEP |
19 |
19,662,337 |
19,697,341 |
RGD:5131438 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
IEP |
12 |
16,151,045 |
16,172,412 |
RGD:2292161 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:6483007 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
IPM |
4 |
151,492,220 |
151,617,331 |
RGD:2301875 |
RGD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
|
IEP |
4 |
69,185,877 |
69,189,080 |
RGD:1599965 |
RGD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
Susceptibility |
ISS |
4 |
69,185,877 |
69,189,080 |
RGD:1599960 |
RGD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
|
ISS |
4 |
69,185,877 |
69,189,080 |
RGD:7240710 |
OMIM |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Onset |
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5508226 |
RGD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
ISS |
20 |
4,730,559 |
4,736,201 |
RGD:5147621 |
RGD |
| G |
Sell |
selectin L |
|
|
IEP |
13 |
79,827,342 |
79,845,296 |
RGD:5685705 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
IEP |
6 |
127,998,617 |
128,021,719 |
RGD:1641805 |
RGD |
| G |
Smo |
smoothened, frizzled family receptor |
|
|
IEP |
4 |
56,623,494 |
56,645,571 |
RGD:2324983 |
RGD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
|
ISS |
18 |
37,090,934 |
37,099,835 |
RGD:1599102 |
RGD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
|
ISS |
18 |
37,090,934 |
37,099,835 |
RGD:2300393 |
RGD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
|
ISS |
9 |
9,788,378 |
9,797,639 |
RGD:1581427 |
RGD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
|
ISS |
4 |
32,649,666 |
32,657,632 |
RGD:5147636 |
RGD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
ISS |
4 |
116,610,595 |
116,780,394 |
RGD:5147636 |
RGD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
IPM |
4 |
116,610,595 |
116,780,394 |
RGD:2304266 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEP |
2 |
175,607,990 |
175,613,992 |
RGD:2312507 |
RGD |
| G |
Tlr3 |
toll-like receptor 3 |
|
|
IEP |
16 |
50,112,910 |
50,126,371 |
RGD:5128695 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144143 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEP |
5 |
83,564,100 |
83,577,735 |
RGD:2312507 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
ISS |
2 |
212,277,654 |
212,297,376 |
RGD:2325163 |
RGD |
| Q |
Bw13 |
Body weight QTL 13 |
|
|
IED |
X |
1 |
41,387,080 |
RGD:619682 |
RGD |
| Q |
Insul4 |
Insulin level QTL 4 |
|
|
IED |
X |
134,157,190 |
160,699,376 |
RGD:619682 |
RGD |
| Q |
Panci1 |
Pancreas inflammation QTL 1 |
|
|
IED |
7 |
123,574,930 |
134,614,033 |
RGD:619682 |
RGD |
Pancreatitis, Acute Necrotizing
|
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
IED |
|
|
|
RGD:2325308 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
IED |
1 |
20,998,894 |
21,011,275 |
RGD:4142795 |
RGD |
| G |
Becn1 |
beclin 1, autophagy related |
|
|
IEP |
10 |
90,317,957 |
90,333,329 |
RGD:6483068 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
IEP |
|
|
|
RGD:2293139 |
RGD |
| G |
Btg2 |
BTG family, member 2 |
|
|
IEP |
13 |
47,026,986 |
47,030,745 |
RGD:2289078 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130168 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
ISS |
|
|
|
RGD:5130168 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
Resistance |
IED |
1 |
172,686,168 |
172,691,061 |
RGD:5684345 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
IEP |
16 |
48,944,226 |
48,962,420 |
RGD:2293324 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Severity |
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2307010 |
RGD |
| G |
Cd46 |
CD46 molecule, complement regulatory protein |
|
Severity |
IEP |
13 |
110,972,812 |
111,003,407 |
RGD:1600479 |
RGD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
Severity |
IEP |
3 |
89,243,600 |
89,245,129 |
RGD:1600479 |
RGD |
| G |
Ctsb |
cathepsin B |
|
|
IEP |
15 |
42,402,829 |
42,423,701 |
RGD:2315517 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5135004 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
Severity |
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:2307010 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEP |
8 |
20,040,177 |
20,051,939 |
RGD:4145335 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:7204517 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:6909141 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
IED |
20 |
13,191,986 |
13,192,851 |
RGD:727512 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
IEP |
19 |
15,246,036 |
15,275,061 |
RGD:7207204 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:2325241 |
RGD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
|
IEP |
|
|
|
RGD:2311232 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
IEP |
1 |
208,262,669 |
208,273,148 |
RGD:2298789 |
RGD |
| G |
Selp |
selectin P |
|
|
IPM |
13 |
79,886,614 |
79,922,180 |
RGD:2312307 |
RGD |
| G |
Serpinf2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
|
IED |
10 |
62,748,116 |
62,756,200 |
RGD:1625538 |
RGD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
IEP |
4 |
116,610,595 |
116,780,394 |
RGD:5147821 |
RGD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
|
IED |
4 |
66,502,253 |
66,677,538 |
RGD:1601470 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEP |
2 |
175,607,990 |
175,613,992 |
RGD:2312724 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEP |
5 |
83,564,100 |
83,577,735 |
RGD:2312724 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
IEP |
|
|
|
RGD:5130184 |
RGD |
Pancreatitis, Alcoholic
|
| G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
|
ISS |
9 |
87,029,500 |
87,098,362 |
RGD:2317503 |
RGD |
Pancreatitis, Chronic
|
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISS |
8 |
49,233,142 |
49,233,431 |
RGD:5685680 |
RGD |
| G |
Dll1 |
delta-like 1 (Drosophila) |
|
|
ISS |
1 |
54,240,395 |
54,248,183 |
RGD:6482236 |
RGD |
| G |
Jag1 |
jagged 1 |
|
|
ISS |
3 |
125,181,063 |
125,216,481 |
RGD:6482236 |
RGD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
|
IEP |
2 |
197,621,726 |
197,632,960 |
RGD:5144071 |
RGD |
| G |
Ngfr |
nerve growth factor receptor |
|
|
ISS |
10 |
84,262,804 |
84,281,006 |
RGD:5508378 |
RGD |
| G |
Prss2 |
protease, serine, 2 |
|
|
ISS |
4 |
69,088,288 |
69,093,312 |
RGD:7240710 |
OMIM |
| Q |
Iddm11 |
Insulin dependent diabetes mellitus QTL 11 |
|
|
IED |
4 |
56,920,444 |
78,042,833 |
RGD:61480 |
RGD |
| Q |
Iddm17 |
Insulin dependent diabetes mellitus QTL 17 |
|
|
IED |
11 |
19,445,919 |
87,759,784 |
RGD:634732 |
RGD |
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease
|
| G |
Sox10 |
SRY (sex determining region Y)-box 10 |
|
|
ISS |
7 |
117,138,694 |
117,149,939 |
RGD:7240710 |
OMIM |
Renal hepatic pancreatic dysplasia Dandy Walker cyst
|
| G |
Nphp3 |
nephronophthisis 3 (adolescent) |
|
|
ISS |
8 |
109,065,400 |
109,105,882 |
RGD:7240710 |
OMIM |
RENAL-HEPATIC-PANCREATIC DYSPLASIA
|
| G |
Nphp3 |
nephronophthisis 3 (adolescent) |
|
|
ISS |
8 |
109,065,400 |
109,105,882 |
RGD:7240710 |
OMIM |
REYNOLDS SYNDROME
|
| G |
Lbr |
lamin B receptor |
|
|
ISS |
13 |
97,814,439 |
97,834,860 |
RGD:7240710 |
OMIM |
Shwachman syndrome
|
| G |
Sbds |
Shwachman-Bodian-Diamond syndrome |
|
|
ISS |
12 |
27,457,313 |
27,466,472 |
RGD:7240710 |
OMIM |
| G |
Sds |
serine dehydratase |
|
|
ISS |
12 |
37,281,091 |
37,288,403 |
RGD:7240710 |
OMIM |
Townes-Brocks syndrome
|
| G |
Sall1 |
sal-like 1 (Drosophila) |
|
|
ISS |
19 |
19,277,337 |
19,293,298 |
RGD:7240710 |
OMIM |
Tropical Calcific Pancreatitis
|
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
|
ISS |
18 |
37,090,934 |
37,099,835 |
RGD:7240710 |
OMIM |
VATER association
|
| G |
Fn1 |
fibronectin 1 |
|
|
IEP |
9 |
70,702,181 |
70,771,155 |
RGD:7205466 |
RGD |
| G |
Hoxd13 |
homeo box D13 |
|
|
ISS |
3 |
57,283,682 |
57,286,998 |
RGD:7240710 |
OMIM |
WAARDENBURG SYNDROME, TYPE 4A
|
| G |
Ednrb |
endothelin receptor type B |
|
|
ISS |
15 |
87,893,141 |
87,898,700 |
RGD:7240710 |
OMIM |
Waardenburg Syndrome, Type 4b
|
| G |
Edn3 |
endothelin 3 |
|
|
ISS |
3 |
166,491,368 |
166,514,051 |
RGD:7240710 |
OMIM |
Waardenburg Syndrome, Type 4c
|
| G |
Sox10 |
SRY (sex determining region Y)-box 10 |
|
|
ISS |
7 |
117,138,694 |
117,149,939 |
RGD:7240710 |
OMIM |
Zellweger Syndrome
|
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
|
ISS |
7 |
129,542,758 |
129,591,363 |
RGD:1300329 |
RGD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
|
ISS |
2 |
218,396,071 |
218,432,172 |
RGD:7240710 |
OMIM |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
Spontaneous |
ISS |
2 |
218,396,071 |
218,432,172 |
RGD:1598658 |
RGD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
|
ISS |
2 |
218,396,071 |
218,432,172 |
RGD:1300330 |
RGD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
|
ISS |
2 |
218,396,071 |
218,432,172 |
RGD:704409 |
RGD |
| G |
Pex1 |
peroxisomal biogenesis factor 1 |
|
|
ISS |
4 |
27,235,147 |
27,275,076 |
RGD:7240710 |
OMIM |
| G |
Pex10 |
peroxisomal biogenesis factor 10 |
|
|
ISS |
5 |
171,868,928 |
171,874,094 |
RGD:7240710 |
OMIM |
| G |
Pex12 |
peroxisomal biogenesis factor 12 |
|
|
IED |
10 |
71,378,818 |
71,382,448 |
RGD:729522 |
RGD |
| G |
Pex13 |
peroxisomal biogenesis factor 13 |
|
|
ISS |
14 |
104,550,699 |
104,571,485 |
RGD:7240710 |
OMIM |
| G |
Pex14 |
peroxisomal biogenesis factor 14 |
|
|
ISS |
5 |
166,038,317 |
166,174,652 |
RGD:7240710 |
OMIM |
| G |
Pex19 |
peroxisomal biogenesis factor 19 |
![GBrowse link GBrowse link]() | |